Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Corcept Therapeutics Incorporated (CORT)

11.96   0.03 (0.25%) 04-18 16:00
Open: 11.85 Pre. Close: 11.93
High: 12.16 Low: 11.74
Volume: 627,129 Market Cap: 1372M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.178 - 12.227 12.227 - 12.278
Low: 11.621 - 11.672 11.672 - 11.723
Close: 11.877 - 11.965 11.965 - 12.055

Technical analysis

as of: 2019-04-18 4:35:07 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 14.60     One year: 17.05
Support: Support1: 11.54    Support2: 10.94
Resistance: Resistance1: 12.50    Resistance2: 14.60
Pivot: 11.87
Moving Average: MA(5): 11.87     MA(20): 11.71
MA(100): 12.73     MA(250): 13.99
MACD: MACD(12,26): 0.01     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 66.92     %D(3): 64.03
RSI: RSI(14): 51.34
52-week: High: 20.00  Low: 9.14  Change(%): -32.0
Average Vol(K): 3-Month: 142745  10-Days: 58776

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CORT has closed below upper band by 40.7%. Bollinger Bands are 69.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to CORT's normal range. The bands have been in this narrow range for 29 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 08 Apr 2019 17:07:58 Z
Corcept (CORT) Rides High on Cushing's Syndrome Drug Korlym

Wed, 27 Mar 2019 15:12:37 Z
Corcept (CORT) Down 6.1% Since Last Earnings Report: Can It Rebound?

Mon, 11 Mar 2019 20:06:55 Z
Here's Why Corcept Therapeutics Shares Rose 11.5% in February

Tue, 26 Feb 2019 22:07:27 Z
Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line

Tue, 26 Feb 2019 20:09:45 Z
Corcept Therapeutics Incorporated (CORT) Q4 2018 Earnings Conference Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 114.72
Shares Float (M) 105.07
% Held by Insiders
% Held by Institutions 121.90
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 0.600
EPS Est. Current Year 0.420
EPS Est. Next Year 0.700
EPS Est. Next Quarter 0.150
Forward EPS 1.420
Book Value (p.s.) 4.990
PEG Ratio -1.22
Profit Margin 29.94
Operating Margin 35.62
Return on Assets (ttm) 28.9
Return on Equity (ttm) 32.9
Qtrly Rev. Growth 25.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -77.60
Operating Cash Flow (M) 115.67
Levered Free Cash Flow (M) 91.00

Stock Valuations

P/E 19.93
P/E Growth Ratio
P/BV 2.40
P/S 629381312.00
P/CF 11.86

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.